Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Dr. Mathieu BurtnykPresident | 11,62k | 76,77k | Derivative Exercise and Retained Stock | 6,61 | 55,17k | 26,68% |
| 2026-06-17 | Mr. Rashed DewanCFO | 7,75k | 51,18k | Derivative Exercise and Retained Stock | 6,61 | 86,07k | 9,89% |
| 2026-06-17 | Mr. Thomas TamberrinoChief Commercial Officer | 10,55k | 69,68k | Derivative Exercise and Retained Stock | 6,61 | 49,79k | 26,87% |
| 2026-06-17 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 70,35k | 464,88k | Derivative Exercise and Retained Stock | 6,61 | 729,01k | 10,68% |
| 2026-06-11 | Mr. Vafa JamaliDirector | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,72 | 20,00k | - |
| 2026-06-11 | Mr. Thomas G. WellnerDirector | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,72 | 20,00k | - |
| 2026-06-11 | Mr. Frank BaylisIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,72 | 20,00k | - |
| 2026-03-20 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 20,00k | 101,92k | Acquisto | 5,10 | 658,66k | 3,13% |
| 2025-12-23 | Mr. Thomas TamberrinoChief Commercial Officer | 13,91k | 99,94k | Acquisto | 7,19 | 39,24k | 54,90% |
| 2025-12-23 | Dr. Arthur L. J. RosenthalIndependent Director | 13,90k | 101,47k | Acquisto | 7,30 | 58,84k | 30,93% |
| 2025-12-23 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 13,40k | 100,00k | Acquisto | 7,47 | 638,66k | 2,14% |
| 2025-11-24 | Ms. Murielle LortieIndependent Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 5,35k | 15,52% |
| 2025-11-24 | Krishan ShahInsider | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 2,20k | 48,48% |
| 2025-11-24 | Dr. Arthur L. J. RosenthalIndependent Director | 868,00 | 5,28k | Derivative Exercise and Retained Stock | 6,08 | 44,94k | 1,97% |
| 2025-11-24 | Mr. Brian R. EllacottIndependent Lead Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 70,20k | 1,03% |
| 2025-11-24 | Dr. Cynthia LavoieIndependent Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 8,20k | 9,61% |
| 2025-11-19 | Dr. Mathieu BurtnykPresident | 1,49k | 9,08k | Derivative Exercise and Retained Stock | 6,11 | 43,55k | 3,53% |
| 2025-11-20 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 4,84k | 29,51k | Derivative Exercise and Retained Stock | 6,10 | 625,26k | 0,78% |
| 2025-11-20 | Mr. Rashed DewanCFO | 1,49k | 9,06k | Derivative Exercise and Retained Stock | 6,10 | 78,33k | 1,93% |
| 2024-11-18 | Krishan ShahInsider | 5,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 5,00k | - |
| 2024-09-08 | Krishan ShahInsider | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 1,48k | - |
| 2024-09-08 | Dr. Arthur L. J. RosenthalIndependent Director | 1,77k | 10,85k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 44,07k | 4,19% |
| 2024-09-08 | Mr. Brian R. EllacottIndependent Lead Director | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 69,48k | 2,18% |
| 2024-09-08 | Ms. Murielle LortieIndependent Director | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 4,63k | 47,08% |
| 2025-09-09 | Dr. Cynthia LavoieIndependent Director | 756,00 | 3,29k | Derivative Exercise and Retained Stock | 4,35 | 7,48k | 11,24% |
| 2025-09-09 | Dr. Mathieu BurtnykPresident | 3,05k | 12,41k | Derivative Exercise and Retained Stock | 4,07 | 42,06k | 7,81% |
| 2025-09-08 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 16,67k | 67,90k | Derivative Exercise and Retained Stock | 4,07 | 620,42k | 2,76% |
| 2025-09-08 | Mr. Rashed DewanCFO | 16,67k | 67,90k | Derivative Exercise and Retained Stock | 4,07 | 76,84k | 27,70% |
| 2025-08-21 | Dr. Mathieu BurtnykPresident | 6,76k | 29,01k | Derivative Exercise and Retained Stock | 4,29 | 39,02k | 20,97% |
| 2025-08-15 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 16,67k | 71,96k | Derivative Exercise and Retained Stock | 4,32 | 603,76k | 2,84% |
| 2025-08-15 | Mr. Rashed DewanCFO | 13,33k | 57,57k | Derivative Exercise and Retained Stock | 4,32 | 60,17k | 28,47% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
